HIV / AIDS in the News

Most Cases of HIV Persistence in Blood Following Treatment Explained by Defective Copies of the Virus - poz.com

 

Gilead’s Weekly PrEP Pill Could Be Approved Early Next Year - poz.com

 

Mississippi’s largest private health insurer updates guidelines for HIV prevention medication - Mississippi Today

 

UN High-Level Meeting on HIV/AIDS - avac.org

 

HIV: East Midlands annual data spotlight 2024 - GOV.UK

 

Uganda introduces checks for polluting cars that kill more than HIV - The Telegraph

 

9 Things You Didn’t Know About (RED) - Smiley Movement

 

Acute Hepatitis C Study Finds High Chemsex Rates and Care Gaps - EMJ

 

'Get PrEP Wise' Via 'Drag Race''s Michelle Visage In ViiV HIV Prevention Campaign 06/16/2026 - MediaPost

 

The Zacks Analyst Blog Highlights Gilead Sciences, Merck and GSK - Yahoo Finance Singapore

 

Rural Indiana struggles with drug-fueled HIV epidemic - WKAR

 

Game-changing HIV prevention drug must be available for $40 per year — everywhere - Doctors Without Borders

 

Cardiometabolic Disease Burden High in ART-Naive Patients With HIV - Infectious Disease Advisor

 

Dolutegravir Improves Long-Term HIV Outcomes in Children and Adolescents - Infectious Disease Advisor

 

Man arrested for failing to disclose HIV-positive status to partner - CBS 42

 

HIV vaccine developed by HK, Shenzhen scientists promises breakthrough - chinadailyasia.com

 

POLITICO: Inside Trump’s reversal on HIV - European AIDS Treatment Group

 

Man arrested for failing to disclose HIV-positive status to partner - WKRG

 

WHO launches first global database on the prevalence of sexually transmitted infections - European AIDS Treatment Group

 

Health Department to offer free HIV testing at Frederick Pride - The Frederick News-Post

 

Baylor College of Medicine: Wastewater analysis offers a new way to monitor HIV in communities - European AIDS Treatment Group

 

UNC School of Medicine: A new HIV vaccine study reveals new hope — and new challenges — for aging patients - European AIDS Treatment Group

 

FDA Accepts sNDA for Lenacapavir Once-Weekly PrEP Pill - Infectious Disease Special Edition

 

[Press release] FDA accepts Gilead’s application for investigational once-weekly oral Yeztugo, potentially the first long-acting pill for HIV prevention - European AIDS Treatment Group

 

Winter Park plastic surgery center settles complaints by patients with HIV, Crohn’s - Orlando Sentinel

 

ACT UP remembers science-minded HIV/AIDS activist Iris Long - Gay City News

 

HIV+ woman among 4 held in MP sex racket - The Times of India

 

Man arrested after allegedly withholding HIV-Positive status from partner - WJHG

 

"I can understand the doubts" - Magic Johnson revealed the real reason NBA players wanted to believe he got HIV because he's gay - Basketball Network

 

WACO Theater Center’s “Still Here Live Experience" brings Black women’s HIV/AIDS stories to Southern salons - Rap-Up